77 related articles for article (PubMed ID: 24725930)
1. Large-scale analysis of influenza A virus nucleoprotein sequence conservation reveals potential drug-target sites.
Kukol A; Hughes DJ
Virology; 2014 Apr; 454-455():40-7. PubMed ID: 24725930
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-cross-linked chemical arrays.
Hagiwara K; Kondoh Y; Ueda A; Yamada K; Goto H; Watanabe T; Nakata T; Osada H; Aida Y
Biochem Biophys Res Commun; 2010 Apr; 394(3):721-7. PubMed ID: 20230782
[TBL] [Abstract][Full Text] [Related]
3. Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.
Davis AM; Ramirez J; Newcomb LL
Virol J; 2017 Feb; 14(1):22. PubMed ID: 28173821
[TBL] [Abstract][Full Text] [Related]
4. Large-scale analysis of influenza A virus sequences reveals potential drug target sites of non-structural proteins.
Darapaneni V; Prabhaker VK; Kukol A
J Gen Virol; 2009 Sep; 90(Pt 9):2124-33. PubMed ID: 19420157
[TBL] [Abstract][Full Text] [Related]
5. Protein sequence conservation and stable molecular evolution reveals influenza virus nucleoprotein as a universal druggable target.
Babar MM; Zaidi NU
Infect Genet Evol; 2015 Aug; 34():200-10. PubMed ID: 26140959
[TBL] [Abstract][Full Text] [Related]
6. Structure and sequence analysis of influenza A virus nucleoprotein.
Ng AK; Wang JH; Shaw PC
Sci China C Life Sci; 2009 May; 52(5):439-49. PubMed ID: 19471866
[TBL] [Abstract][Full Text] [Related]
7. A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.
Kakisaka M; Sasaki Y; Yamada K; Kondoh Y; Hikono H; Osada H; Tomii K; Saito T; Aida Y
PLoS Pathog; 2015 Jul; 11(7):e1005062. PubMed ID: 26222066
[TBL] [Abstract][Full Text] [Related]
8. Location and architecture of an antibody-binding site of influenza A virus nucleoprotein.
Varich NL; Sadykova GK; Prilipov AG; Kochergin-Nikitsky KS; Webster RG; Kaverin NV
Arch Virol; 2014 Jun; 159(6):1493-7. PubMed ID: 24357080
[TBL] [Abstract][Full Text] [Related]
9. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA.
Ye Q; Krug RM; Tao YJ
Nature; 2006 Dec; 444(7122):1078-82. PubMed ID: 17151603
[TBL] [Abstract][Full Text] [Related]
10. Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development.
Liu CL; Hung HC; Lo SC; Chiang CH; Chen IJ; Hsu JT; Hou MH
Sci Rep; 2016 Feb; 6():21662. PubMed ID: 26916998
[TBL] [Abstract][Full Text] [Related]
11. Designing and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoprotein.
Ahmad A; Javed MR; Rao AQ; Husnain T
BMC Complement Altern Med; 2016 Dec; 16(1):519. PubMed ID: 27986088
[TBL] [Abstract][Full Text] [Related]
12. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
13. A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins.
Weber F; Kochs G; Gruber S; Haller O
Virology; 1998 Oct; 250(1):9-18. PubMed ID: 9770415
[TBL] [Abstract][Full Text] [Related]
14. [Clone expression and purification of influenza A virus nucleoprotein gene].
Fang SS; Cheng XW; Liu T; Liu JJ; Zhao SJ; Zhou L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):165-8. PubMed ID: 16027788
[TBL] [Abstract][Full Text] [Related]
15. The role of the N-terminal caspase cleavage site in the nucleoprotein of influenza A virus in vitro and in vivo.
Lipatov AS; Yen HL; Salomon R; Ozaki H; Hoffmann E; Webster RG
Arch Virol; 2008; 153(3):427-34. PubMed ID: 18058063
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary conservation of influenza A PB2 sequences reveals potential target sites for small molecule inhibitors.
Patel H; Kukol A
Virology; 2017 Sep; 509():112-120. PubMed ID: 28628827
[TBL] [Abstract][Full Text] [Related]
17. Global geno-proteomic analysis reveals cross-continental sequence conservation and druggable sites among influenza virus polymerases.
Babar MM; Zaidi NU; Tahir M
Antiviral Res; 2014 Dec; 112():120-31. PubMed ID: 25446404
[TBL] [Abstract][Full Text] [Related]
18. Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine.
Anhlan D; Hrincius ER; Scholtissek C; Ludwig S
Vaccine; 2012 Jun; 30(30):4480-9. PubMed ID: 22575164
[TBL] [Abstract][Full Text] [Related]
19. A highly conserved region of the Sendai virus nucleocapsid protein contributes to the NP-NP binding domain.
Myers TM; Pieters A; Moyer SA
Virology; 1997 Mar; 229(2):322-35. PubMed ID: 9126246
[TBL] [Abstract][Full Text] [Related]
20. Structurally conserved binding sites of hemagglutinin as targets for influenza drug and vaccine development.
Yusuf M; Konc J; Sy Bing C; Trykowska Konc J; Ahmad Khairudin NB; Janezic D; Wahab HA
J Chem Inf Model; 2013 Sep; 53(9):2423-36. PubMed ID: 23980878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
